why choose us

Clinical Trials Search

Showing 19,130 of 132,963 result(s)
Next Generation Ingestible Sensors for Medication Adherence Measurement

Status: Completed

Condition: HIV Infection

Interventions: The digital pill system (DPS) is comprised of an ingestible radiofrequency emitter, integrated into a standard gelatin capsule, which then over-encaps

Date: 2022-10-12

CalPeg for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

Status: Completed

Condition: Acute Lymphoblastic Leukemia

Interventions:

Hyper-CVAD consists of two combinations of drugs (courses A and B) given in an alternating fashion.
The term "hyper" refers to the h

Date: 2022-10-12

Examining Different Components of Online Acceptance and Commitment Therapy for People With Chiari Malformation

Status: ACTIVE_NOT_RECRUITING

Condition: Chronic Pain

Interventions:

The intervention has 8 modules.
The modules "Away Moves" and "Letting Go of Control," help to establish creative hopelessn

Date: 2022-10-12

CML Pediatric ITK Response According to Molecular Identification at Diagnosis

Status: Completed

Condition: Chronic Myeloid Leukemia

Interventions: Targeted Next Generation Sequencing (DNA and RNA)

Date: 2022-10-12

A Randomized Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP Pts

Status: COMPLETED

Condition: Previously Treated Primary Immune Thrombocytopenia

Interventions: initial therapy: rhTPO s.c, 300 or 600U;kg daily based on baseline platelet count; maintenance therapy: rhTPO s.c, 300 ~ 600U;kg every other

Date: 2022-10-12

A Double-blind Study to Evaluate the Safety of Glutamic Acid Decarboxylase Gene Transfer in Parkinson's Participants

Status: COMPLETED

Condition: Parkinson Disease

Interventions: Bilateral infusion of AAV-GAD Dose 1

Date: 2022-10-12

Assess the Performance of Metagenomic Sequencing in the Diagnosis of STI (NGS-IST)

Status: COMPLETED

Condition: Sexually Transmitted Infections (Not HIV or Hepatitis)

Interventions:

Proposal of the study to all eligible adult patients coming for pre-exposure prophylaxis (PrEP) consultations from the Infectious Diseases Departme

Date: 2022-10-12

Evaluation of the Evolution of Quality of Life in Relation to Naso-sinus Symptomatology Under Treatment With CFTE Modulators in Children Aged 6 to 11 Years With Cystic Fibrosis With Compatible Mutation

Status: COMPLETED

Condition: Cystic Fibrosis

Interventions: Introduction of CFTR modulators by pneumologists for pneumologic issues

Date: 2022-10-12

Leading Well-being and the Psychosocial Working Environment - A Cluster-randomized Waitlist Controlled Trial

Status: Completed

Condition: Stress

Interventions:

The intervention comprises five training modules with practice in small groups in between.
Training will take place over 5 months.
The tr

Date: 2022-10-12